Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 1
1(16.7%)
6Total
N/A(5)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07452562Not ApplicableRecruiting

Hesperidin RCT in MS

Role: collaborator

NCT05683002Not ApplicableActive Not Recruiting

Aronia, Cognition, and Eye Health (ACE)

Role: collaborator

NCT05133778Not ApplicableCompleted

The Effect of Sweet Orange and Pomegranate Extract Supplementation on Exercise Capacity in Middle-aged Adults

Role: collaborator

NCT03793777Not ApplicableCompleted

The Effect of Aronia Melanocarpa Extract on Cognitive Function

Role: collaborator

NCT03236259Not ApplicableCompleted

The Effect of Berry Extract Administration on Cognitive Health

Role: collaborator

NCT01896154Phase 1Completed

Pilot Study on Effect Size of Non-digestible Polysaccharides (NPS) on Immunity

Role: collaborator

All 6 trials loaded